The 15-20 National Hospital and GenSight Biologics Announce the First Treatments in the French Named Patient Early Access Program (AAC) for GS010/LUMEVOQ®businesswire.com
Milestone Pharmaceuticals Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analystsbenzinga.com
KD Investors Have Opportunity to Lead Kyndryl Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firmprnewswire.com
Paysafe Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PSFEprnewswire.com
BellRing Brands, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BRBRprnewswire.com
Novartis to Acquire Synnovation Therapeutics' Pan-Mutant Selective PI3Kα Inhibitor Programbusinesswire.com
Standard Chartered, BSI lose bid to join cases in Singapore winding up firms with assets linked to 1MDBreuters.com
Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipelineglobenewswire.com